Alliancebernstein L.P. Sells 95,550 Shares of agilon health, inc. (NYSE:AGL)

Alliancebernstein L.P. reduced its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 381,390 shares of the company's stock after selling 95,550 shares during the period. Alliancebernstein L.P. owned 0.09% of agilon health worth $725,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the stock. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter worth about $25,000. Ieq Capital LLC acquired a new stake in agilon health during the fourth quarter worth approximately $26,000. Signaturefd LLC increased its holdings in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after purchasing an additional 8,467 shares in the last quarter. Raymond James Financial Inc. acquired a new position in agilon health in the fourth quarter valued at approximately $33,000. Finally, Symphony Financial Services Inc. boosted its holdings in shares of agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after buying an additional 7,058 shares in the last quarter.

agilon health Stock Performance

Shares of agilon health stock traded down $0.13 during trading hours on Wednesday, reaching $3.92. The company had a trading volume of 3,852,908 shares, compared to its average volume of 4,800,758. The firm has a market cap of $1.61 billion, a PE ratio of -4.15 and a beta of 0.38. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The business has a fifty day simple moving average of $4.16 and a 200 day simple moving average of $3.13.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Cowen reiterated a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $3.30 to $8.50 in a research report on Tuesday, April 8th. Finally, Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and raised their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, agilon health currently has a consensus rating of "Hold" and a consensus price target of $4.60.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.